Inside EU Health Inside EU Health: Cancer-causing chemicals; patient groups want HTA improvements; benefits of investing in innovative medicines EU agrees tougher protections against cancer-causing chemicals; patient groups welcome progress on EU HTA while calling for further improvements; every €1 invested in innovative medicines returns €5.67 in benefits, claims EFPIA
Inside EU Health Inside EU Health: Europe invests in 10-year preparedness research plan; Biotech Act I rapporteurs; EU and Canada health agencies joint plan; HTA report Europe invests €240 million ten-year pandemic preparedness research; Biotech Act I rapporteurs confirmed; EU and Canada health agencies deepen ties; HTA annual report on first year of implementation
Inside EU Health Inside EU Health: Pharma trilogue advances; reinforcing EU preparedness; EFPIA concerns on HTA process Pharma trilogue talks advance; reinforcing EU preparedness; and EFPIA raises concerns on HTA process
